Press Resease

Radiotherapy Market - Global Industry Analysis

Radiotherapy Market By Product (External beam radiation therapy, Compact Advanced Radiotherapy Systems, and Proton Therapy Systems), By Technology (External Beam Radiation Therapy, Internal Radiation Therapy, and Systemic Radiation Therapy), By Application (External Beam Radiation Therapy, and Internal Radiation Therapy): Global Industry Perspective, Comprehensive Analysis and Forecast, 2020 – 2028

Published Date: 18-Aug-2021 Category: Medical Device Report Format : PDF Pages: 150 Report Code: ZMR-1296 Status : Published

The global Radiotherapy market accounted for USD 6.9 Billion in 2020 and is expected to reach USD 11.9 Billion by 2028, growing at a CAGR of 7.1% from 2021 to 2028.

Description

Market Overview                                                  

The global Radiotherapy market accounted for USD 6.9 Billion in 2020 and is expected to reach USD 11.9 Billion by 2028, growing at a CAGR of 7.1% from 2021 to 2028.      

Radiotherapy is a treatment for cancer that uses radiation, usually X-rays, to treat illness. Radiotherapy is also sometimes used to treat benign tumors and other conditions, such as thyroid disease and some blood disorders. Radiotherapy is used alone or in combination with chemotherapy (chemoradiotherapy) to treat cancer. Radiotherapy is effective in controlling symptoms of cancer. Radiotherapy may be used before surgery or after surgery to destroy small tumor cells that may be left. Radiotherapy can be external, internal or systemic.

The players are focusing aggressively on innovation, as well as on including advanced technologies in their existing Products. Over the coming years, they are also expected to take up partnerships and mergers and acquisitions as their key strategy for business development. For example, in 2020, Elekta (Sweden) introduced its Elekta Harmony linear accelerator, a cancer treatment system with a shorter treatment slot of up to 25% and a 30% smaller footprint. In 2020, PMB, a subsidiary of the ALCEN Group, announced the launch of FLASHKNiFE, a FLASH radiotherapy system dedicated to clinical trials.

COVID-19 Impact Analysis:

The lockdowns imposed by various countries to contain the spread of Covid-19 has impacted the global operations and supply chain which had a negative consequences on Radiotherapy market as the global sales declined. As healthcare professionals increasingly direct their resources towards caring for coronavirus-infected patients, other health issues are being relegated to the back seat. The players in the industry have temporarily suspended the production of Radiotherapy products in order to cater corona virus patients.

The normal decrease in the global Radiotherapy market size in 2020 is estimated on the basis of the COVID-19 outbreak and its negative impact on the economies and industries across the globe. Various scenarios have been analyzed on the basis of inputs from various secondary sources and the current data available about the situation.  

Global Radiotherapy Market Size

Growth Factors  

Global radiotherapy market is primarily driven by growing incidences of cancer across the globe. Other major driving factors are increasing geriatric population and large government funding. However, lack of infrastructure and lack of skilled personnel and training are the major restraints that may limit the growth of the market. Nonetheless, technological advancements in radiotherapy products coupled with a huge investment in radiotherapy across the globe are likely to disclose the new avenues for radiotherapy market in the near future.

Report Scope:

Report Attribute Details
Base Year 2020
Historic Years 2016 - 2020
Forecast Years 2021 - 2028
Segments Covered By Product Type, By Application, and By End Use
Forecast Units Value (USD Billion), and Volume (Units)
Quantitative Units Revenue in USD million/billion and CAGR from 2021 to 2028
Regions Covered North America, Europe, Asia Pacific, Latin America, and Middle East & Africa, and Rest of World
Countries Covered U.S., Canada, Mexico, U.K., Germany, France, Italy, Spain, China, India, Japan, South Korea, Brazil, Argentina, GCC Countries, and South Africa, among others
Number of Companies Covered 10 companies with scope for including additional 15 companies upon request
Report Coverage Market growth drivers, restraints, opportunities, Porter’s five forces analysis, PEST analysis, value chain analysis, regulatory landscape, market attractiveness analysis by segments and region, company market share analysis, and COVID-19 impact analysis.
Customization Scope Avail customized purchase options to meet your exact research needs.

Product Segment Analysis Preview

On the basis of Product, the market is segmented into external beam radiation therapy, internal radiation therapy (brachytherapy), and systemic radiation therapy. External beam radiation therapy is further sub-segmented into compact advanced radiotherapy systems (Cyberknife, Gamma knife, and Tomotherapy), proton therapy systems (Cyclotron and Synchrotron) and electron emitting high energy linear accelerators (Linac). Internal radiation therapy is further sub-classified into seeds, applicators & after leaders and electronic brachytherapy. External beam radiation therapy holds a maximum share of global radiotherapy market.  

Technology Segment Analysis Preview

On the basis of Technology, Radiotherapy market is segmented into external beam radiation therapy (Image-Guided Radiotherapy (IGRT), Intensity Modulated Radiotherapy (IMRT), Stereotactic Technology, Proton Beam Therapy, Tomotherapy, 3D Conformal Radiotherapy (3D CRT) and Volumetric Modulated Arc Therapy (VMAT)), internal radiation therapy (Low Dose Rate and High Dose Rate), and systemic radiation therapy.

Global Radiotherapy Market Share

Application Segment Analysis Preview  

On the basis of Application, the market is segmented into external beam radiation therapy, and Internal radiation therapy. External beam radiation therapy is classified into prostate cancer, breast cancer, lung cancer, head & neck cancer, colorectal cancer and other. Internal radiation therapy is classified into prostate cancer, gynecological cancer, breast cancer, penile cancer and other.

Regional Segment Analysis Preview

North America is anticipated to remain the leading region over the forecast period followed by Europe. Demand for radiotherapy was highest in North America especially in the U.S. Asia Pacific is expected to be the moderate growing region in radiotherapy market during the forecast period. Moreover, the Middle East and Africa and Latin America are also expected to show moderate growth for this market in the years to come.

Global Radiotherapy Market Regional Analysis

Key Market Players & Competitive Landscape

The major players operating in the Radiotherapy market are Elekta AB, Varian Medical Systems, Accuray Incorporated, IBA Worldwide, IsoRay Medical, Inc., Nordion, Inc., Raysearch Laboratories, Mevion Medical Systems, Mitsubishi Electric Corporation and C. R. Bard, Inc. among others.

The global Radiotherapy market is segmented as follows:   

By Product

  • External beam radiation therapy
  • Compact Advanced Radiotherapy Systems
      • Cyberknife
      • Gamma Knife
      • Tomotherapy
  • Proton Therapy Systems
      • Cyclotron
      • Synchrotron
  • Electron Emitting High Energy Linear Accelerators (Linac)
  • Internal Radiation Therapy/Brachytherapy
    • Seeds
    • Applicators & Afterloaders
    • Electronic Brachytherapy
  • Systemic Radiation Therapy

By Technology  

  • External Beam Radiation Therapy
    • Image-Guided Radiotherapy (IGRT)
    • Intensity Modulated Radiotherapy (IMRT)
    • Stereotactic Technology
    • Proton Beam Therapy
    • Tomotherapy
    • 3D Conformal Radiotherapy (3D CRT)
    • Volumetric Modulated Arc Therapy (VMAT)
  • Internal Radiation Therapy
    • Low Dose Rate
    • High Dose Rate
  • Systemic Radiation Therapy

By Application

  • External Beam Radiation Therapy
    • Prostate Cancer
    • Breast Cancer
    • Lung Cancer
    • Head & Neck Cancer
    • Colorectal Cancer
    • Other
  • Internal Radiation Therapy
    • Prostate Cancer
    • Gynecological Cancer
    • Breast Cancer
    • Penile Cancer
    • Other

By Region

  • North America
    • The U.S.
    • Canada
  • Europe
    • France
    • The UK
    • Spain
    • Germany
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC
    • South Africa
    • Rest of Middle East & Africa

Table Of Content

  • Chapter No. 1 Introduction
    • 1.1. Report Description
      • 1.1.1. Purpose of the Report
      • 1.1.2. USP & Key Offerings
    • 1.2. Key Benefits for Stakehulders
    • 1.3. Target Audience
    • 1.4. Report Scope
  • Chapter No. 2 Executive Summary
    • 2.1. Key Findings
      • 2.1.1. Top Investment Pockets
        • 2.1.1.1. Market Attractiveness Analysis, By Product
        • 2.1.1.2. Market Attractiveness Analysis, By Technology
        • 2.1.1.3. Market Attractiveness Analysis, By Application
        • 2.1.1.4. Market Attractiveness Analysis, By Region
    • 2.2. Market Snapshot
    • 2.3. Global Radiotherapy Market, 2016 – 2028 (USD Billion)
    • 2.4. Insights from Primary Respondents
  • Chapter No. 3 COVID 19 Impact Analysis
    • 3.1. Impact Assessment of COVID-19 Pandemic, By Region
      • 3.1.1. North America
      • 3.1.2. Europe
      • 3.1.3. Asia Pacific
      • 3.1.4. Latin America
      • 3.1.5. The Middle-East and Africa
    • 3.2. Quarterly Market Revenue and Forecast by Region 2020 & 2021
    • 3.3. Pre COVID-19 Market Revenue, By Region, 2016-2019 (USD Billion)
    • 3.4. Post COVID-19 Market Revenue, By Region, 2020-2028 (USD Billion)
    • 3.5. Key Strategies Undertaken by Companies to Tackle COVID-19
      • 3.5.1. Company Quarterly Revenue Analysis, 2019 & 2020
    • 3.6. Short Term Dynamics
    • 3.7. Long Term Dynamics
  • Chapter No. 4 Radiotherapy Market – Product Segment Analysis
    • 4.1. Overview
      • 4.1.1. Market Revenue Share, By Product, 2020 & 2028
    • 4.2. External beam radiation therapy
      • 4.2.1. Market Application and Forecast, By Region (USD Billion)
      • 4.2.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 4.2.3. Key Market Trends, Growth Factors, & Opportunities
    • 4.3. Compact Advanced Radiotherapy Systems
      • 4.3.1. Market Application and Forecast, By Region (USD Billion)
      • 4.3.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 4.3.3. Key Market Trends, Growth Factors, & Opportunities
      • 4.3.4. Cyberknife
      • 4.3.4.1 Key Market Trends, Growth Factors, & Opportunities
      • 4.3.5. Gamma Knife
      • 4.3.5.1 Key Market Trends, Growth Factors, & Opportunities
      • 4.3.6. Tomotherapy
      • 4.3.6.1 Key Market Trends, Growth Factors, & Opportunities
    • 4.7. Proton Therapy Systems
      • 4.7.1. Market Application and Forecast, By Region (USD Billion)
      • 4.7.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 4.7.3. Key Market Trends, Growth Factors, & Opportunities
      • 4.8.1. Cyclotron
      • 4.8.1.1 Key Market Trends, Growth Factors, & Opportunities
      • 4.8.2. Synchrotron
      • 4.8.2.1 Key Market Trends, Growth Factors, & Opportunities
    • 4.9. Electron Emitting High Energy Linear Accelerators (Linac)
      • 4.9.1. Market Application and Forecast, By Region (USD Billion)
      • 4.9.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 4.9.3. Key Market Trends, Growth Factors, & Opportunities
    • 4.10. Internal Radiation Therapy/Brachytherapy
      • 4.10.1. Market Application and Forecast, By Region (USD Billion)
      • 4.10.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 4.10.3. Key Market Trends, Growth Factors, & Opportunities
      • 4.11.1. Seeds
      • 4.11.1.1 Key Market Trends, Growth Factors, & Opportunities
      • 4.12.1. Applicators & Afterloaders
      • 4.12.1.1 Key Market Trends, Growth Factors, & Opportunities
      • 4.13.1. Electronic Brachytherapy
      • 4.13.1.1 Key Market Trends, Growth Factors, & Opportunities
    • 4.14. Systemic Radiation Therapy
      • 4.14.1. Market Application and Forecast, By Region (USD Billion)
      • 4.14.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 4.14.3. Key Market Trends, Growth Factors, & Opportunities
  • Chapter No. 5 Radiotherapy Market – Technology Segment Analysis
    • 5.1. Overview
      • 5.1.1. Market Revenue Share, By Technology, 2020 & 2028
    • 5.2. External Beam Radiation Therapy
      • 5.2.1. Market Application and Forecast, By Region (USD Billion)
      • 5.2.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 5.2.3. Key Market Trends, Growth Factors, & Opportunities
    • 5.3. Image-Guided Radiotherapy (IGRT)
      • 5.3.1. Key Market Trends, Growth Factors, & Opportunities
    • 5.4. Intensity Modulated Radiotherapy (IMRT)
      • 5.4.1. Key Market Trends, Growth Factors, & Opportunities
    • 5.5. Stereotactic Technology
      • 5.5.1. Key Market Trends, Growth Factors, & Opportunities
    • 5.6. Proton Beam Therapy
      • 5.6.1. Key Market Trends, Growth Factors, & Opportunities
    • 5.7. Tomotherapy
      • 5.7.1. Key Market Trends, Growth Factors, & Opportunities
    • 5.8. 3D Conformal Radiotherapy (3D CRT)
      • 5.8.1. Key Market Trends, Growth Factors, & Opportunities
    • 5.9. Vulumetric Modulated Arc Therapy (VMAT)
      • 5.9.1. Key Market Trends, Growth Factors, & Opportunities
    • 5.10. Internal Radiation Therapy
      • 5.10.1. Market Application and Forecast, By Region (USD Billion)
      • 5.10.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 5.10.3. Key Market Trends, Growth Factors, & Opportunities
    • 5.11. Low Dose Rate
      • 5.11.1. Key Market Trends, Growth Factors, & Opportunities
    • 5.12. High Dose Rate
      • 5.12.1. Key Market Trends, Growth Factors, & Opportunities
    • 5.13. Systemic Radiation Therapy
      • 5.13.1. Market Application and Forecast, By Region (USD Billion)
      • 5.13.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 5.13.3. Key Market Trends, Growth Factors, & Opportunities
  • Chapter No. 6 Radiotherapy Market – Application Segment Analysis
    • 6.1. Overview
      • 6.1.1. Market Revenue Share, By Application, 2020 & 2028
    • 6.2. External Beam Radiation Therapy
      • 6.2.1. Market Application and Forecast, By Region (USD Billion)
      • 6.2.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 6.2.3. Key Market Trends, Growth Factors, & Opportunities
    • 6.3. Prostate Cancer
      • 6.3.1. Key Market Trends, Growth Factors, & Opportunities
    • 6.4. Breast Cancer
      • 6.4.1. Key Market Trends, Growth Factors, & Opportunities
    • 6.5. Lung Cancer
      • 6.5.1. Key Market Trends, Growth Factors, & Opportunities
    • 6.6. Head & Neck Cancer
      • 6.6.1. Key Market Trends, Growth Factors, & Opportunities
    • 6.7. Culorectal Cancer
      • 6.7.1. Key Market Trends, Growth Factors, & Opportunities
    • 6.8. Others
      • 6.8.1. Key Market Trends, Growth Factors, & Opportunities
    • 6.9. Internal Radiation Therapy
      • 6.9.1. Market Application and Forecast, By Region (USD Billion)
      • 6.9.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 6.9.3. Key Market Trends, Growth Factors, & Opportunities
    • 6.10. Prostate Cancer
      • 6.10.1. Key Market Trends, Growth Factors, & Opportunities
    • 6.11. Gyneculogical Cancer
      • 6.11.1. Key Market Trends, Growth Factors, & Opportunities
    • 6.12. Breast Cancer
      • 6.12.1. Key Market Trends, Growth Factors, & Opportunities
    • 6.13. Penile Cancer
      • 6.13.1. Key Market Trends, Growth Factors, & Opportunities
    • 6.14. Others
      • 6.14.1. Key Market Trends, Growth Factors, & Opportunities
  • Chapter No. 7 Radiotherapy Market – Regional Analysis
    • 7.1. Overview
      • 7.1.1. Global Market Revenue Share, By Region, 2020 & 2028
      • 7.1.2. Global Market Revenue, By Region, 2016 – 2028 (USD Billion)
    • 7.2. North America
      • 7.2.1. North America Market Revenue, By Country, 2016 – 2028 (USD Billion)
      • 7.2.2. North America Market Revenue, By Product, 2016 – 2028
      • 7.2.3. North America Market Revenue, By Technology, 2016 – 2028
      • 7.2.4. North America Market Revenue, By Application, 2016 – 2028
      • 7.2.5. U.S.
        • 7.2.5.1. U.S. Market Revenue, By Product, 2016 – 2028
        • 7.2.5.2. U.S. Market Revenue, By Technology, 2016 – 2028
        • 7.2.5.3. U.S. Market Revenue, By Application, 2016 – 2028
      • 7.2.6. Canada
        • 7.2.6.1. Canada Market Revenue, By Product, 2016 – 2028
        • 7.2.6.2. Canada Market Revenue, By Technology, 2016 – 2028
        • 7.2.6.3. Canada Market Revenue, By Application, 2016 – 2028
      • 7.2.7. Mexico
        • 7.2.7.1. Mexico Market Revenue, By Product, 2016 – 2028
        • 7.2.7.2. Mexico Market Revenue, By Technology, 2016 – 2028
        • 7.2.7.3. Mexico Market Revenue, By Application, 2016 – 2028
    • 7.3. Europe
      • 7.3.1. Europe Market Revenue, By Country, 2016 – 2028 (USD Billion)
      • 7.3.2. Europe Market Revenue, By Product, 2016 – 2028
      • 7.3.3. Europe Market Revenue, By Technology, 2016 – 2028
      • 7.3.4. Europe Market Revenue, By Application, 2016 – 2028
      • 7.3.5. Germany
        • 7.3.5.1. Germany Market Revenue, By Product, 2016 – 2028
        • 7.3.5.2. Germany Market Revenue, By Technology, 2016 – 2028
        • 7.3.5.3. Germany Market Revenue, By Application, 2016 – 2028
      • 7.3.6. France
        • 7.3.6.1. France Market Revenue, By Product, 2016 – 2028
        • 7.3.6.2. France Market Revenue, By Technology, 2016 – 2028
        • 7.3.6.3. France Market Revenue, By Application, 2016 – 2028
      • 7.3.7. U.K.
        • 7.3.7.1. U.K. Market Revenue, By Product, 2016 – 2028
        • 7.3.7.2. U.K. Market Revenue, By Technology, 2016 – 2028
        • 7.3.7.3. U.K. Market Revenue, By Application, 2016 – 2028
      • 7.3.8. Italy
        • 7.3.8.1. Italy Market Revenue, By Product, 2016 – 2028
        • 7.3.8.2. Italy Market Revenue, By Technology, 2016 – 2028
        • 7.3.8.3. Italy Market Revenue, By Application, 2016 – 2028
      • 7.3.9. Spain
        • 7.3.9.1. Spain Market Revenue, By Product, 2016 – 2028
        • 7.3.9.2. Spain Market Revenue, By Technology, 2016 – 2028
        • 7.3.9.3. Spain Market Revenue, By Application, 2016 – 2028
      • 7.3.10. Rest of Europe
        • 7.3.10.1. Rest of Europe Market Revenue, By Product, 2016 – 2028
        • 7.3.10.2. Rest of Europe Market Revenue, By Technology, 2016 – 2028
        • 7.3.10.3. Rest of Europe Market Revenue, By Application, 2016 – 2028
    • 7.4. Asia Pacific
      • 7.4.1. Asia Pacific Market Revenue, By Country, 2016 – 2028 (USD Billion)
      • 7.4.2. Asia Pacific Market Revenue, By Product, 2016 – 2028
      • 7.4.3. Asia Pacific Market Revenue, By Technology, 2016 – 2028
      • 7.4.4. Asia Pacific Market Revenue, By Application, 2016 – 2028
      • 7.4.5. China
        • 7.4.5.1. China Market Revenue, By Product, 2016 – 2028
        • 7.4.5.2. China Market Revenue, By Technology, 2016 – 2028
        • 7.4.5.3. China Market Revenue, By Application, 2016 – 2028
      • 7.4.6. Japan
        • 7.4.6.1. Japan Market Revenue, By Product, 2016 – 2028
        • 7.4.6.2. Japan Market Revenue, By Technology, 2016 – 2028
        • 7.4.6.3. Japan Market Revenue, By Application, 2016 – 2028
      • 7.4.7. India
        • 7.4.7.1. India Market Revenue, By Product, 2016 – 2028
        • 7.4.7.2. India Market Revenue, By Technology, 2016 – 2028
        • 7.4.7.3. India Market Revenue, By Application, 2016 – 2028
      • 7.4.8. South Korea
        • 7.4.8.1. South Korea Market Revenue, By Product, 2016 – 2028
        • 7.4.8.2. South Korea Market Revenue, By Technology, 2016 – 2028
        • 7.4.8.3. South Korea Market Revenue, By Application, 2016 – 2028
      • 7.4.9. South-East Asia
        • 7.4.9.1. South-East Asia Market Revenue, By Product, 2016 – 2028
        • 7.4.9.2. South-East Asia Market Revenue, By Technology, 2016 – 2028
        • 7.4.9.3. South-East Asia Market Revenue, By Application, 2016 – 2028
      • 7.4.10. Rest of Asia Pacific
        • 7.4.10.1. Rest of Asia Pacific Market Revenue, By Product, 2016 – 2028
        • 7.4.10.2. Rest of Asia Pacific Market Revenue, By Technology, 2016 – 2028
        • 7.4.10.3. Rest of Asia Pacific Market Revenue, By Application, 2016 – 2028
    • 7.5. Latin America
      • 7.5.1. Latin America Market Revenue, By Country, 2016 – 2028 (USD Billion)
      • 7.5.2. Latin America Market Revenue, By Product, 2016 – 2028
      • 7.5.3. Latin America Market Revenue, By Technology, 2016 – 2028
      • 7.5.4. Latin America Market Revenue, By Application, 2016 – 2028
      • 7.5.5. Brazil
        • 7.5.5.1. Brazil Market Revenue, By Product, 2016 – 2028
        • 7.5.5.2. Brazil Market Revenue, By Technology, 2016 – 2028
        • 7.5.5.3. Brazil Market Revenue, By Application, 2016 – 2028
      • 7.5.6. Argentina
        • 7.5.6.1. Argentina Market Revenue, By Product, 2016 – 2028
        • 7.5.6.2. Argentina Market Revenue, By Technology, 2016 – 2028
        • 7.5.6.3. Argentina Market Revenue, By Application, 2016 – 2028
      • 7.5.7. Rest of Latin America
        • 7.5.7.1. Rest of Latin America Market Revenue, By Product, 2016 – 2028
        • 7.5.7.2. Rest of Latin America Market Revenue, By Technology, 2016 – 2028
        • 7.5.7.3. Rest of Latin America Market Revenue, By Application, 2016 – 2028
    • 7.6. The Middle-East and Africa
      • 7.6.1. The Middle-East and Africa Market Revenue, By Country, 2016 – 2028 (USD Billion)
      • 7.6.2. The Middle-East and Africa Market Revenue, By Product, 2016 – 2028
      • 7.6.3. The Middle-East and Africa Market Revenue, By Technology, 2016 – 2028
      • 7.6.4. The Middle-East and Africa Market Revenue, By Application, 2016 – 2028
      • 7.6.5. GCC Countries
        • 7.6.5.1. GCC Countries Market Revenue, By Product, 2016 – 2028
        • 7.6.5.2. GCC Countries Market Revenue, By Technology, 2016 – 2028
        • 7.6.5.3. GCC Countries Market Revenue, By Application, 2016 – 2028
      • 7.6.6. South Africa
        • 7.6.6.1. South Africa Market Revenue, By Product, 2016 – 2028
        • 7.6.6.2. South Africa Market Revenue, By Technology, 2016 – 2028
        • 7.6.6.3. South Africa Market Revenue, By Application, 2016 – 2028
      • 7.6.7. Rest of Middle-East Africa
        • 7.6.7.1. Rest of Middle-East Africa Market Revenue, By Product, 2016 – 2028
        • 7.6.7.2. Rest of Middle-East Africa Market Revenue, By Technology, 2016 – 2028
        • 7.6.7.3. Rest of Middle-East Africa Market Revenue, By Application, 2016 – 2028
  • Chapter No. 8 Radiotherapy Market – Industry Analysis
    • 8.1. Introduction
    • 8.2. Market Drivers
      • 8.2.1. Driving Factor 1 Analysis
      • 8.2.2. Driving Factor 2 Analysis
    • 8.3. Market Restraints
      • 8.3.1. Restraining Factor Analysis
    • 8.4. Market Opportunities
      • 8.4.1. Market Opportunity Analysis
    • 8.5. Porter’s Five Forces Analysis
    • 8.6. PEST Analysis
    • 8.7. Regulatory Landscape
    • 8.8. Product Landscape
    • 8.9. Regional Market Trends
      • 8.9.1. North America
      • 8.9.2. Europe
      • 8.9.3. Asia Pacific
      • 8.9.4. Latin America
      • 8.9.5. The Middle-East and Africa
    • 8.10. Pricing Analysis
    • 8.11. Value Chain Analysis
    • 8.12. Downstream Buyers
    • 8.13. Distributors/Traders List
  • Chapter No. 9 Competitive Landscape
    • 9.1. Company Market Share Analysis – 2019
      • 9.1.1. Global Radiotherapy Market: Company Market Share, 2019
      • 9.1.2. Global Radiotherapy Market, Company Market Revenue, 2016 – 2019 (USD Billion)
      • 9.1.3. Global Radiotherapy Market, Company Y-o-Y Growth, 2017 – 2019 (%)
      • 9.1.4. Global Radiotherapy Market: Radar Determinant Chart, 2019
    • 9.2. Strategic Developments
      • 9.2.1. Acquisitions & Mergers
      • 9.2.2. New Product Launch
      • 9.2.3. Regional Expansion
    • 9.3. Company Strategic Developments – Heat Map Analysis
  • Chapter No. 10 Company Profiles
    • 10.1. Elekta AB
      • 10.1.1. Company Overview
      • 10.1.2. Key Executives
      • 10.1.3. Product Portfolio
      • 10.1.4. Financial Overview
      • 10.1.5. Operating Business Segments
      • 10.1.6. Business Performance
      • 10.1.7. Recent Developments
    • 10.2. Varian Medical Systems
    • 10.3. Accuray Incorporated
    • 10.4. IBA Worldwide
    • 10.5. IsoRay Medical, Inc
    • 10.6. Nordion, Inc
    • 10.7. Raysearch Laboratories
    • 10.8. Mevion Medical Systems
    • 10.9. Mitsubishi Electric Corporation
    • 10.10. C. R. Bard, Inc
  • Chapter No. 11 Marketing Strategy Analysis
    • 11.1. Marketing Channel
    • 11.2. Direct Marketing
    • 11.3. Indirect Marketing
    • 11.4. Marketing Channel Development Trends
    • 11.5. Economic/Pulitical Technology Change
  • Chapter No. 12 Research Methodology
    • 12.1. Research Methodology
    • 12.2. Phase I - Secondary Research
    • 12.3. Phase II - Data Modeling
      • 12.3.1. Company Share Analysis Model
      • 12.3.2. Revenue Based Modeling
    • 12.4. Phase III - Primary Research
    • 12.5. Research Limitations
      • 12.5.1. Assumptions

List of Figures 

FIG NO. 1. Market Attractiveness Analysis, By Product
FIG NO. 2. Market Attractiveness Analysis, By Technology
FIG NO. 4. Market Attractiveness Analysis, By Region
FIG NO. 5. Global Radiotherapy Market Revenue, 2016 – 2028 (USD Billion)
FIG NO. 6. Impact of COVID-19 Pandemic in North America Countries
FIG NO. 7. Market Revenue Share, By Product, 2020 & 2028 
FIG NO. 8. Global Radiotherapy Market for External beam radiation therapy, Revenue (USD Billion) 2016 – 2028
FIG NO. 9. Comparative Revenue Analysis of Radiotherapy Market for External beam radiation therapy, By Country, 2020 & 2028
FIG NO. 10. Global Radiotherapy Market for Compact Advanced Radiotherapy Systems, Revenue (USD Billion) 2016 – 2028
FIG NO. 11. Comparative Revenue Analysis of Radiotherapy Market for Compact Advanced Radiotherapy Systems, By Country, 2020 & 2028
FIG NO. 12. Global Radiotherapy Market for Proton Therapy Systems, Revenue (USD Billion) 2016 – 2028
FIG NO. 13. Comparative Revenue Analysis of Radiotherapy Market for Proton Therapy Systems, By Country, 2020 & 2028 
FIG NO. 14. Global Radiotherapy Market for Electron Emitting High Energy Linear Accelerators (Linac), Revenue (USD Billion) 2016 – 2028
FIG NO. 15. Comparative Revenue Analysis of Radiotherapy Market for Electron Emitting High Energy Linear Accelerators (Linac, By Country, 2020 & 2028 
FIG NO. 16. Global Radiotherapy Market for Internal Radiation Therapy/Brachytherapy, Revenue (USD Billion) 2016 – 2028
FIG NO. 17. Comparative Revenue Analysis of Radiotherapy Market for Internal Radiation Therapy/Brachytherapy, By Country, 2020 & 2028 
FIG NO. 18. Global Radiotherapy Market for Systemic Radiation Therapy, Revenue (USD Billion) 2016 – 2028
FIG NO. 19. Comparative Revenue Analysis of Radiotherapy Market for Systemic Radiation Therapy, By Country, 2020 & 2028 
FIG NO. 20. Market Revenue Share, By Technology, 2020 & 2028
FIG NO. 21. Global Radiotherapy Market for External Beam Radiation Therapy, Revenue (USD Billion) 2016 – 2028
FIG NO. 22. Comparative Revenue Analysis of Radiotherapy Market for External Beam Radiation Therapy, By Country, 2020 & 2028
FIG NO. 23. Global Radiotherapy Market for Internal Radiation Therapy, Revenue (USD Billion) 2016 – 2028
FIG NO. 24. Comparative Revenue Analysis of Radiotherapy Market for Internal Radiation Therapy, By Country, 2020 & 2028
FIG NO. 25. Global Radiotherapy Market for Systemic Radiation Therapy, Revenue (USD Billion) 2016 – 2028
FIG NO. 26. Comparative Revenue Analysis of Radiotherapy Market for Systemic Radiation Therapy, By Country, 2020 & 2028
FIG NO. 27. Market Revenue Share, By Application, 2020 & 2028
FIG NO. 28. Global Radiotherapy Market for External Beam Radiation Therapy, Revenue (USD Billion) 2016 – 2028
FIG NO. 29. Comparative Revenue Analysis of Radiotherapy Market for External Beam Radiation Therapy, By Country, 2020 & 2028
FIG NO. 30. Global Radiotherapy Market for Internal Radiation Therapy, Revenue (USD Billion) 2016 – 2028
FIG NO. 31. Comparative Revenue Analysis of Radiotherapy Market for Internal Radiation Therapy, By Country, 2020 & 2028
FIG NO. 32. Global Radiotherapy Market Revenue Share, By Region, 2020 & 2028
FIG NO. 33. North America Radiotherapy Market Revenue, 2016 - 2028 (USD Billion)
FIG NO. 34. Porter’s Five Forces Analysis for Global Radiotherapy Market
FIG NO. 35. PEST Analysis for Global Radiotherapy Market
FIG NO. 36. Pricing Analysis for Global Radiotherapy Market
FIG NO. 37. Value Chain Analysis for Global Radiotherapy Market
FIG NO. 38. Company Share Analysis, 2019
FIG NO. 39. Radar Determinant Chart, 2019
FIG NO. 40. Company Strategic Developments – Heat Map Analysis
FIG NO. 41. Elekta AB Business Segment Revenue Share, 2020 (%)
FIG NO. 42. Elekta AB Geographical Segment Revenue Share, 2020 (%)
FIG NO. 43. Market Channels
FIG NO. 44. Marketing Channel Development Trend
FIG NO. 45. Growth in World Gross Product, 2008-2018
FIG NO. 46. Research Methodology – Detailed View
FIG NO. 47. Research Methodology 
 


List of Tables 

TABLE NO. 1. Global Radiotherapy Market: Snapshot
TABLE NO. 2. Quarterly Radiotherapy Market Revenue by Region, 2020
TABLE NO. 3. Quarterly Radiotherapy Market Revenue Forecast by Region, 2021
TABLE NO. 4. Pre COVID-19 Market Revenue, By Region, 2016-2019 (USD Billion)
TABLE NO. 5. Post COVID-19 Market Revenue, By Region, 2020-2028 (USD Billion)
TABLE NO. 6. Global Radiotherapy Market for External beam radiation therapy, by Region, 2016 – 2028 (USD Billion)
TABLE NO. 7. Global Radiotherapy Market for Compact Advanced Radiotherapy Systems, by Region, 2016 – 2028 (USD Billion)
TABLE NO. 8. Global Radiotherapy Market for Proton Therapy Systems, by Region, 2016 – 2028 (USD Billion)
TABLE NO. 9 Global Radiotherapy Market for Electron Emitting High Energy Linear Accelerators (Linac), by Region, 2016 – 2028 (USD Billion) 
TABLE NO. 10 Global Radiotherapy Market for Internal Radiation Therapy/Brachytherapy, by Region, 2016 – 2028 (USD Billion)
TABLE NO. 11: Global Radiotherapy Market for Systemic Radiation Therapy, by Region, 2016 – 2028 (USD Billion)
TABLE NO. 12 Global Radiotherapy Market for External Beam Radiation Therapy, by Region, 2016 – 2028 (USD Billion)
TABLE NO. 13 Global Radiotherapy Market for Internal Radiation Therapy, by Region, 2016 – 2028 (USD Billion)
TABLE NO. 14 Global Radiotherapy Market for Systemic Radiation Therapy, by Region, 2016 – 2028 (USD Billion)
TABLE NO. 15: Global Radiotherapy Market for External Beam Radiation Therapy, by Region, 2016 – 2028 (USD Billion)
TABLE NO. 16: Global Radiotherapy Market for Internal Radiation Therapy, by Region, 2016 – 2028 (USD Billion)
TABLE NO. 17. G6obal Radiotherapy Market Revenue, By Region, 2016 – 2028 (USD Billion)
TABLE NO. 18. North America Radiotherapy Market Revenue, By Country, 2016 – 2028 (USD Billion)
TABLE NO. 19 North America Radiotherapy Market Revenue, By Product, 2016 – 2028 (USD Billion)
TABLE NO. 20. North America Radiotherapy Market Revenue, By Technology, 2016 – 2028 (USD Billion)
TABLE NO. 21. North America Radiotherapy Market Revenue, By Application, 2016 – 2028 (USD Billion)
TABLE NO. 22. U.S. Radiotherapy Market Revenue, By Product, 2016 – 2028 (USD Billion)
TABLE NO. 23. U.S. Radiotherapy Market Revenue, By Technology, 2016 – 2028 (USD Billion)
TABLE NO. 24. U.S. Radiotherapy Market Revenue, By Application, 2016 – 2028 (USD Billion)
TABLE NO. 25. Canada Radiotherapy Market Revenue, By Product, 2016 – 2028 (USD Billion)
TABLE NO. 26. Canada Radiotherapy Market Revenue, By Technology, 2016 – 2028 (USD Billion)
TABLE NO. 27. Canada Radiotherapy Market Revenue, By Application, 2016 – 2028 (USD Billion)
TABLE NO. 28. Mexico Radiotherapy Market Revenue, By Product, 2016 – 2028 (USD Billion) 
TABLE NO. 29. Mexico Radiotherapy Market Revenue, By Technology, 2016 – 2028 (USD Billion)
TABLE NO. 30. Mexico Radiotherapy Market Revenue, By Application, 2016 – 2028 (USD Billion)
TABLE NO. 31. Drivers for the Radiotherapy Market: Impact Analysis
TABLE NO. 32. Restraints for the Radiotherapy Market: Impact Analysis
TABLE NO. 33. Major Buyers of Radiotherapy  
TABLE NO. 34. Distributors/Traders List of Radiotherapy 
TABLE NO. 35. Global Radiotherapy Market, Company Market Revenue, 2016 – 2019 (USD Billion)
TABLE NO. 36. Global Radiotherapy Market, Company Y-o-Y Growth, 2017 – 2019 (USD Billion)

Methodology

This report is based on in-depth qualitative and quantitative analyses of the global Radiotherapy market. Zion Research has collected and analyzed key data belong to the global Radiotherapy market using a variety of methods. Quantitative analysis has been done following various projection and sampling techniques.

The qualitative analysis involved primary interviews, surveys, and vendor briefings. The data gathered as a result of these processes were validated through experts' opinions. The market dynamics have been determined after conducting a detailed study of the micro and macroeconomic indicators of the market.

Various parameters have been taken into account, while estimating market size. The revenue generated by the leading industry participants in from the sales of Radiotherapy across the world has been calculated through primary and secondary research.

Zion Research employs the combination of secondary research followed by extensive primary research. Under secondary research, we refer to prominent paid as well as open access data sources including product literature, company annual reports, government publications, press releases, industry association’s magazines and other relevant sources for data collection. Other prominent secondary sources include STATISTA, trade journals, trade associations, statistical data from government websites, etc. 

For this study, Zion Research has conducted all-encompassing primary research with key industry participants to collect first had data. Moreover, in-depth interviews with key opinion leaders also assisted in validation of findings from secondary research and to understand key trends in the Radiotherapy industry. Primary research makes up the major source of data collection and validation.   

Primary Research

We conduct primary interviews with industry participants and commentators on an ongoing basis to validate data and analysis. A typical research interview fulfills the following functions:

  • Provides firsthand information on market size, market trends, growth trends, competitive landscape, outlook, etc.
  • Helps in validating and strengthening the secondary research findings
  • Further, develops the analysis team’s expertise and market understanding
  • Primary research involves e-mail interactions, telephonic interviews as well as face-to-face interviews for each market, category, segment and sub-segment across geographies

Participants who typically participate in such a process include, but are not limited to:

  • Industry participants: CEOs, VPs, marketing/product managers, market intelligence managers and national sales managers
  • Purchasing managers, technical personnel, distributors and resellers
  • Outside experts: Investment bankers, valuation experts and research analysts specializing in specific markets

Key opinion leaders specializing in different areas corresponding to different industry verticals

Secondary Research

Secondary research sources that are typically referred to include, but are not limited to:

  • Company websites, annual reports, financial reports, broker reports, investor presentations and SEC filings
  • IDC and other relevant magazines
  • Internal and external proprietary databases, and relevant patent and regulatory databases
  • National government documents, statistical databases and market reports

News articles, press releases and webcasts specific to companies operating in the market

Following a comprehensive secondary and primary research and insights thus gathered, analysts at Zion Research have provided an in-depth analysis of various aspects of the Radiotherapy market.

Models

Where no hard data is available, we use models and estimates to produce comprehensive data sets. A rigorous methodology is adopted, wherein the available hard data is cross-referenced with the following data types to produce estimates:

  • Demographic data: Population split by segments
  • Macroeconomic indicators: GDP, PPP, Per Capita Income, etc.
  • Industry indicators: Expenditure, technology stage and infrastructure, sector growth and facilities
  • Data is then cross-checked by an expert panel.

Free Analysis

Cancer can be defined as uncontrolled growth of the cell. Cancer starts when cells grow out of control and outnumber normal cells. Uncontrolled growth of cell leads to the formation of the tumor which can interfere normal cell functioning. Radiation therapy uses high-energy X-rays to destroy or injure cancer cells and to cease the growth. Radiation therapy can be used to treat cancer. About 4 out of 10 people with cancer (40%) have radiotherapy as part of their treatment. It is given in various ways, from outside the body as external radiotherapy, using X-rays from linear accelerator machines, electrons, and more rarely other particles such as protons and from within the body as internal radiotherapy, by drinking a liquid that is taken up by cancer cells or by putting radioactive material in, or close to, the tumor.

According to the American Cancer Society, cancer is the second most common cause of death in the U.S. and accounts for nearly 1 of every 4 deaths. The World Health Organization estimates that, worldwide, there were 14 million new cancer cases and 8.2 million cancer-related deaths in 2012. There are over 200 different types of cancer and each of which is classified by the type of cell that is initially affected. Various types of cancer include prostate cancer, blood cancer, lungs cancer etc. The treatment of cancer has become of prime importance owing to increase in a number of global cancer patients. Different types of drugs are administered to cancer patients depending upon therapy used to treat the patient and type of cancer.

Global-Radiotherapy-Market

Increasing prevalence of cancer across the globe is expected to be the major driver for the global radiotherapy market. In addition, increasing geriatric population coupled with large government funding is expected to trigger the growth of global radiotherapy industry in the coming years. However, lack of infrastructure coupled with the lack of skilled personnel and training may pose the challenge to radiotherapy market. Nevertheless, technological advancements in radiotherapy products coupled with the huge investment in radiotherapy across the globe are expected to act an opportunity for radiotherapy market in near future.

Based on product, radiotherapy market has been segmented into external beam radiation therapy, internal radiation therapy (brachytherapy), and systemic radiation therapy. External beam radiation therapy is further sub-segmented into compact advanced radiotherapy systems (Cyberknife, Gamma knife, and Tomotherapy), proton therapy systems (Cyclotron and Synchrotron) and electron emitting high energy linear accelerators (Linac). Internal radiation therapy is further sub-classified into seeds, applicators & after leaders and electronic brachytherapy. External beam radiation therapy holds the maximum share of global radiotherapy market.

Based on technology radiotherapy market is classified into external beam radiation therapy (Image-Guided Radiotherapy (IGRT), Intensity Modulated Radiotherapy (IMRT), Stereotactic Technology, Proton Beam Therapy, Tomotherapy, 3D Conformal Radiotherapy (3D CRT) and Volumetric Modulated Arc Therapy (VMAT)), internal radiation therapy (Low Dose Rate and High Dose Rate), and systemic radiation therapy.

Based on applications external beam radiation therapy segment is classified into prostate cancer, breast cancer, lung cancer, head & neck cancer, colorectal cancer and other. Internal radiation therapy is classified into prostate cancer, gynecological cancer, breast cancer, penile cancer and other.

North America is expected to remain the dominant region over the forecast period. Increasing healthcare awareness is expected to boost the market in this region. Europe was the second largest market followed by Asia-Pacific. Asia-Pacific is expected to show fastest growth rate during the forecast period while Latin America market is projected to grow at a moderate rate during the forecast period. The Middle East and Africa are also expected to experience noticeable growth in the years to come.

Some of the key players in radiotherapy market include Elekta AB, Varian Medical Systems, Accuray Incorporated, IBA Worldwide, IsoRay Medical, Inc., Nordion, Inc., Raysearch Laboratories, Mevion Medical Systems, Mitsubishi Electric Corporation and C. R. Bard, Inc. among others.

Choose License Type

Request the coronavirus impact analysis across industries and markets

FrequentlyAsked Questions

The global Radiotherapy market was valued at USD 6.9 Billion in 2020.

The global Radiotherapy market is expected to reach USD 11.9 Billion by 2028, growing at a CAGR of 7.1% between 2021 to 2028.

Major driving factors for the growth of Radiotherapy market are increasing geriatric population and large government funding.  

North America is anticipated to remain the leading region over the forecast period followed by Europe. Demand for radiotherapy was highest in North America especially in the U.S.

The major players operating in the Radiotherapy market are Elekta AB, Varian Medical Systems, Accuray Incorporated, IBA Worldwide, IsoRay Medical, Inc., Nordion, Inc., Raysearch Laboratories, Mevion Medical Systems, Mitsubishi Electric Corporation and C. R. Bard, Inc. among others.

HappyClients

Office Address

Contact Us

Zion Market Research
Tel: +1 (844) 845-5245
USA/Canada Toll Free No.+1 (855) 465-4651

Asia Pacific Office

3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No 020-46277770

Contact #

US OFFICE NO +1 (844) 845-5245
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com

We Are On Social

Business Hours

Our support available to help you 24 hours a day, five days a week.

Monday - Friday: 9AM - 6PM

Saturday - Sunday: Closed